Search

everythinglearnresearchcommunity

for

Search:↓

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

Skin tumors and normal skin structures have different lectin-binding patterns.

The environment around the time of conception can change the VTRNA2-1 gene in a way that lasts for years and may affect disease risk.

TLR2 is important for hair growth and can be targeted to treat hair loss.

NGAL may help maintain skin balance and is linked to skin disorders and cancers.

A rare benign scalp tumor in an infant requires surgical removal.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

CLE14 peptide promotes root hair growth in Arabidopsis.

Mouse hair keratins mHa1 and mHb4 can't form a strong network on their own in cells.

Mutations in the KRT85 gene cause hair and nail problems.

Progesterone helps adult male mice's brain cells survive and improves learning and memory.

Vitamin D receptor interacts with certain dietary components to help prevent diseases and regulate hair growth.

Four botanical extracts were found to quickly attract neutrophils to wounded skin in zebrafish.

JMJD3 and NF-κB activate Notch1, which is essential for skin cell movement and wound healing.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Calretinin can help identify certain skin structures and tumors.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

Collagen XXII is a marker for tissue junctions, aiding in structural integrity and found in muscles, heart, skin, and arthritic joints.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

A specific molecular switch, driven by MAPK/ERK signaling, helps spiny mice heal wounds by regenerating skin instead of forming scars.

Euph E and Euri A from Euphorbia neriifolia help control inflammation and immune response in cells.

P144® improves hypertrophic scars by reducing size and thickness and increasing elasticity.

Using DNase enzymes to break down harmful NETs could be a new treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.